| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12086-0.2mg | |||
| Azide and BSA Free | NBP3-12086-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12048-0.2mg | |||
| Azide and BSA Free | NBP3-12048-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12003-0.2mg | |||
| Azide and BSA Free | NBP3-12003-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11989-0.2mg | |||
| Azide and BSA Free | NBP3-11989-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12086-0.2mg | |||
| Azide and BSA Free | NBP3-12086-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81040-0.025mg | |||
| Azide and BSA Free | NBP2-81040-0.2mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11997-0.2mg | |||
| Azide and BSA Free | NBP3-11997-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11996-0.2mg | |||
| Azide and BSA Free | NBP3-11996-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52660-0.2mg | |||
| Azide and BSA Free | NBP2-52660-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75907SS | |||
| Azide and BSA Free | NBP2-75907-0.2mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81095-0.2mg | |||
| Azide and BSA Free | NBP2-81095-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75898SS | |||
| Azide and BSA Free | NBP2-75898-0.2mg | |||
![CD25/IL-2R alpha Antibody (Daclizumab) [Alexa Fluor® 532] - Chimeric [NBP2-52660AF532] - Vial of Alexa Fluor 532 conjugated antibody. Alexa Fluor 532 is optimally excited at 532 nm by the Yellow-Green laser (561 nm) and has an emission maximum of 554 nm.](http://images.novusbio.com/fullsize/nbp2-52660af532_rabbit-monoclonal-cd25-il-2r-alpha-antibody-daclizumab-alexa-fluor-532-chimeric-31720238224333.jpg "CD25/IL-2R alpha Antibody (Daclizumab) [Alexa Fluor® 532] - Chimeric [NBP2-52660AF532] - Vial of Alexa Fluor 532 conjugated antibody. Alexa Fluor 532 is optimally excited at 532 nm by the Yellow-Green laser (561 nm) and has an emission maximum of 554 nm.")
![Product Image: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [Alexa Fluor® 647] [NBP2-75907AF647] - Vial of Alexa Fluor 647 conjugated antibody. Alexa Fluor 647 is optimally excited at 653 nm by the Red laser (633 or 640 nm) and has an emission maximum of 669 nm.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-hu5c8-Ruplizumab-Alexa-Fluor-R-647-Product-Image-NBP2-75907AF647-img0001.jpg "Product Image: CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [Alexa Fluor® 647] [NBP2-75907AF647] - Vial of Alexa Fluor 647 conjugated antibody. Alexa Fluor 647 is optimally excited at 653 nm by the Red laser (633 or 640 nm) and has an emission maximum of 669 nm.")
![TNF-alpha Antibody (cA2 (Infliximab)) [Alexa Fluor® 350] - Chimeric [NBP2-75898AF350] - Vial of Alexa Fluor 350 conjugated antibody. Alexa Fluor 350 is optimally excited at 346 nm by the UV laser (350 or 355 nm) and has an emission maximum of 442 nm.](http://images.novusbio.com/fullsize/nbp2-75898af350_human-monoclonal-tnf-alpha-antibody-ca2-infliximab-alexa-fluor-350-chimeric-288202315203275.jpg "TNF-alpha Antibody (cA2 (Infliximab)) [Alexa Fluor® 350] - Chimeric [NBP2-75898AF350] - Vial of Alexa Fluor 350 conjugated antibody. Alexa Fluor 350 is optimally excited at 346 nm by the UV laser (350 or 355 nm) and has an emission maximum of 442 nm.")